Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Analyst Comments: Infosys, China Mobile, Dynavax, CarMax, Arena Pharmaceuticals
Jul 10, 2008 07:00 PM
- Analyst Comments: Acergy, Trimeris, Emageon, Dynavax, Newcastle, Kyocera, Alexza Pharma, Kirby Corporation
Mar 19, 2008 08:24 PM
- Dynavax, Merck: FDA Puts Clinical Hold On HEPLISAV Vaccine
Mar 17, 2008 03:30 PM
- Analyst Comments: 3Com, Allscripts, NDS Group, Dynavax, Crocs, D.R. Horton, Onyx Pharmaceuticals, Home Diagnostics
Feb 20, 2008 01:25 PM
- Dynavax, Merck & Co. Set Partnership To Develop Heplisav
Nov 01, 2007 04:48 AM
- Dynavax, Merck & Co. Set Partnership To Develop Heplisav
Nov 01, 2007 04:48 AM
- PETER BRIMELOW: InsiderInsights Urges Nimbleness In Face Of Uncertain Market
May 11, 2007 12:24 AM
- UPDATE: Dynavax Shares Set New High On Hepatitis B Vaccine Data
Nov 29, 2006 01:04 PM
- UPDATE: Dynavax Shares Set New High On Hepatitis B Vaccine Data
Nov 29, 2006 01:04 PM
- UPDATE: Dynavax Rockets On Allergy Study
Oct 05, 2006 12:43 PM
- Dynavax Announces Listing Transfer to The Nasdaq Capital Market from The Nasdaq Global Market
Nov 25, 2008 09:04 AM
- Dynavax Announces Receipt of Notice of Failure to Satisfy a Continued Listing Rule from The Nasdaq Global Market
Nov 14, 2008 04:32 PM
- Dynavax to Present at Credit Suisse Healthcare Conference
Nov 06, 2008 04:43 PM
- Dynavax Announces Third Quarter 2008 Financial Results
Nov 03, 2008 08:26 AM
- Dynavax to Report Third Quarter 2008 Financial Results
Oct 30, 2008 04:48 PM
- Beacon Equity Issues Technical Trade Alerts on Market Movers: DVAX, TLAB, CRESY, HSNI, SCMR, NAPS
Oct 24, 2008 09:01 AM
- Dynavax and Merck & Co., Inc. Provide Update on U.S. FDA Clinical Hold on Investigational Vaccine HEPLISAV(TM)
Oct 21, 2008 05:27 PM
- Dynavax Awarded $17 Million Contract from National Institutes of Health
Sep 29, 2008 09:17 AM
- Dynavax Receives Milestone from AstraZeneca
Sep 22, 2008 09:11 AM
- Dynavax Announces Second Quarter 2008 Financial Results
Aug 05, 2008 04:18 PM
- Form 3 DYNAVAX TECHNOLOGIES For: Oct 23 Filed by: BVF PARTNERS L P/IL (10K)
Oct 24, 2008 06:28 PM
- Form 4 Flynn James E For: Oct 22 (10K)
Oct 24, 2008 01:46 PM
- Form 4 DYNAVAX TECHNOLOGIES For: Oct 03 Filed by: COFFMAN ROBERT (10K)
Oct 07, 2008 04:55 PM
- Form 4 DYNAVAX TECHNOLOGIES For: Oct 03 Filed by: DINA DINO (10K)
Oct 07, 2008 04:55 PM
- Form 4 DYNAVAX TECHNOLOGIES For: Oct 03 Filed by: OSTRACH MICHAEL S (10K)
Oct 07, 2008 04:55 PM
- Form 4 DYNAVAX TECHNOLOGIES For: Oct 03 Filed by: SANDERS MARTIN E (10K)
Oct 07, 2008 04:55 PM
- Form 4 DYNAVAX TECHNOLOGIES For: Oct 03 Filed by: SMELTZER DEBORAH A (10K)
Oct 07, 2008 04:55 PM
- Form 4 DYNAVAX TECHNOLOGIES For: Dec 27 Filed by: DEERFIELD PRIVATE DESIGAN FUND L P (10K)
Jun 30, 2008 04:44 PM
- Form 4 DYNAVAX TECHNOLOGIES For: Jun 12 Filed by: CARSON DENNIS (10K)
Jun 13, 2008 11:46 AM
- Form 4 DYNAVAX TECHNOLOGIES For: Jun 12 Filed by: LAWRENCE DAVID M (10K)
Jun 13, 2008 11:46 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
DVAX
|
Compare to S&P
|
| YTD |
-95.31 %
|
-92.31 %
|
| 4 Weeks |
-20.03 %
|
-13.56 %
|
| 12 Weeks |
-83.68 %
|
-77.38 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 6.67 %
|
|
EPS Growth in Last Year: 67.44 %
|
|
Sales Growth in Last Quarter: -11.23 %
|
|
Sales Growth in Last Quarter: 773.47 %
|
|
|
